Welcome to LookChem.com Sign In|Join Free

CAS

  • or

179187-31-6

Post Buying Request

179187-31-6 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

179187-31-6 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 179187-31-6 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,7,9,1,8 and 7 respectively; the second part has 2 digits, 3 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 179187-31:
(8*1)+(7*7)+(6*9)+(5*1)+(4*8)+(3*7)+(2*3)+(1*1)=176
176 % 10 = 6
So 179187-31-6 is a valid CAS Registry Number.

179187-31-6SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 13, 2017

Revision Date: Aug 13, 2017

1.Identification

1.1 GHS Product identifier

Product name methyl 2-((tert-butoxy)-carbonylamino)-3-(2-hydroxyphenyl)propanoate

1.2 Other means of identification

Product number -
Other names methyl 2-((tert-butyloxycarbonyl)amino)-3-(2-hydroxyphenyl)propanoate

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:179187-31-6 SDS

179187-31-6Relevant articles and documents

Synthesis of Diverse Macrocyclic Peptidomimetics Utilizing Ring-Closing Metathesis and Solid-Phase Synthesis

Barrett, Anthony G. M.,Hennessy, Alan J.,Le Vezouet, Ronan,Procopiou, Panayiotis A.,Seale, Peter W.,Stefaniak, Stefan,Upton, Richard J.,White, Andrew J. P.,Williams, David J.

, p. 1028 - 1037 (2007/10/03)

The synthesis of a range of highly functionalized peptidomimetic macrocycles has been accomplished using ring-closing metathesis and enyne tandem cross-metathesis-ring-closing metathesis reactions. This approach gives access to rigidified macrocycles mode

LTB4 antagonists and radiopharmaceuticals for imaging infection and inflammation

-

, (2008/06/13)

The present invention provides novel radiopharmaceutials useful for the diagnosis of infection and inflammation, reagents and kits useful for preparing the radiopharmaceuticals, methods of imaging sites of infection and/or inflammation in a patient, and methods of diagnosing diseases associated with infection or inflammation in patients in need of such diagnosis. The radiopharmaceuticals bind in vivo to the leukotriene B4 (LTB4) receptor on the surface of leukocytes which accumulate at the site of infection and inflammation. The reagents provided by this invention are also useful for the treatment of diseases associated with infection and inflammation.

Radiopharmaceuticals for imaging infection and inflammation

-

, (2008/06/13)

The present invention provides novel radiopharmaceuticals useful for the diagnosis of infection and inflammation, reagents and kits useful for preparing the radiopharmaceuticals, methods of imaging sites of infection and/or inflammation in a patient, and

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 179187-31-6